The Cost-effectiveness of the Plasma Microbial Cell-free DNA (mcfDNA) Sequencing Karius Test® to Establish an Etiology of Pneumonia Amongst Hospitalized Immunocompromised Adult Patients With Hematologic Malignancy or Prior Hematopoietic Cell Transplantation
Publication
, Conference
Sutton, AJ; Lupu, DS; Bergin, SP; Holland, TL; McAdams, SA; Nguyen, K; Tremblay, G; Perkins, BA
Published in: AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
2024
Duke Scholars
Published In
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
EISSN
1535-4970
ISSN
1073-449X
Publication Date
2024
Volume
209
Related Subject Headings
- Respiratory System
- 3202 Clinical sciences
- 3201 Cardiovascular medicine and haematology
- 11 Medical and Health Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Sutton, A. J., Lupu, D. S., Bergin, S. P., Holland, T. L., McAdams, S. A., Nguyen, K., … Perkins, B. A. (2024). The Cost-effectiveness of the Plasma Microbial Cell-free DNA (mcfDNA) Sequencing Karius Test® to Establish an Etiology of Pneumonia Amongst Hospitalized Immunocompromised Adult Patients With Hematologic Malignancy or Prior Hematopoietic Cell Transplantation. In AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (Vol. 209).
Sutton, A. J., D. S. Lupu, S. P. Bergin, T. L. Holland, S. A. McAdams, K. Nguyen, G. Tremblay, and B. A. Perkins. “The Cost-effectiveness of the Plasma Microbial Cell-free DNA (mcfDNA) Sequencing Karius Test® to Establish an Etiology of Pneumonia Amongst Hospitalized Immunocompromised Adult Patients With Hematologic Malignancy or Prior Hematopoietic Cell Transplantation.” In AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, Vol. 209, 2024.
Sutton AJ, Lupu DS, Bergin SP, Holland TL, McAdams SA, Nguyen K, et al. The Cost-effectiveness of the Plasma Microbial Cell-free DNA (mcfDNA) Sequencing Karius Test® to Establish an Etiology of Pneumonia Amongst Hospitalized Immunocompromised Adult Patients With Hematologic Malignancy or Prior Hematopoietic Cell Transplantation. In: AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE. 2024.
Sutton, A. J., et al. “The Cost-effectiveness of the Plasma Microbial Cell-free DNA (mcfDNA) Sequencing Karius Test® to Establish an Etiology of Pneumonia Amongst Hospitalized Immunocompromised Adult Patients With Hematologic Malignancy or Prior Hematopoietic Cell Transplantation.” AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, vol. 209, 2024.
Sutton AJ, Lupu DS, Bergin SP, Holland TL, McAdams SA, Nguyen K, Tremblay G, Perkins BA. The Cost-effectiveness of the Plasma Microbial Cell-free DNA (mcfDNA) Sequencing Karius Test® to Establish an Etiology of Pneumonia Amongst Hospitalized Immunocompromised Adult Patients With Hematologic Malignancy or Prior Hematopoietic Cell Transplantation. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE. 2024.
Published In
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
EISSN
1535-4970
ISSN
1073-449X
Publication Date
2024
Volume
209
Related Subject Headings
- Respiratory System
- 3202 Clinical sciences
- 3201 Cardiovascular medicine and haematology
- 11 Medical and Health Sciences